
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Cancer Research, Vol 2, Issue 10 1751-1756, Copyright © 1996 by American Association for Cancer Research
ARTICLES |
DP Rose, JM Connolly and M Coleman
Division of Nutrition and Endocrinology, American Health Foundation, Valhalla, New York 10595, USA.
We showed previously that a diet rich in linoleic acid (LA), an omega-6 fatty acid, stimulates the growth and metastasis of human breast cancer cells in athymic nude mice. In contrast, diets supplemented with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), omega-3 fatty acids, exert suppressive effects. We have now assessed EPA and DHA as adjuvant nutritional therapy in the nude mouse model and compared the responses when the intervention was commenced 1 week before ("neoadjuvant") or immediately after ("postoperative adjuvant") surgical excision of the primary tumor. Female nude mice received a high-fat, 8% LA diet beginning 7 days before 10(6) MDA-MB-435 human breast cancer cells were injected into a thoracic mammary fat pad. As the tumor surface areas approached 0. 7 cm2, the mice were assigned to either continue on the LA-rich diet or to commence one containing 8, 4, or 2% EPA or DHA. Seven days later, the mammary fat pad tumors were excised; the mice still consuming the 8% LA diet were then allocated sequentially to either continue this diet or commence one of the six postexcision omega-3 fatty acid dietary interventions. Eight weeks later, the mice were necropsied and evaluated for local recurrence and lung metastases. Although there were no differences in the incidence of local recurrence between groups, EPA and DHA both inhibited the development of lung metastases. When the dietary interventions were commenced 7 days before surgery, the severity of lung metastasis was reduced by the two omega-3 fatty acids in a dose-dependent manner; at all three levels, the suppressive effects were statistically significant (P < 0.05). Postexcision EPA treatment produced small, statistically insignificant effects, but lung involvement was reduced significantly by feeding DHA at the 2 and 4% levels (P < 0. 05). Overall, these results suggest that omega-3 fatty acids may have a place as adjuvant nutritional therapy in breast cancer and particularly as part of a neoadjuvant regimen.
This article has been cited by other articles:
![]() |
S. Lee, K. M. Gura, S. Kim, D. A. Arsenault, B. R. Bistrian, and M. Puder Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids Nutr Clin Pract, August 1, 2006; 21(4): 323 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Yance Jr and S. M. Sagar Targeting angiogenesis with integrative cancer therapies. Integr Cancer Ther, March 1, 2006; 5(1): 9 - 29. [Abstract] [PDF] |
||||
![]() |
H. Sun, I. M. Berquin, and I. J. Edwards Omega-3 Polyunsaturated Fatty Acids Regulate Syndecan-1 Expression in Human Breast Cancer Cells Cancer Res., May 15, 2005; 65(10): 4442 - 4447. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Xia, J. Wang, and J. X. Kang Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes Carcinogenesis, April 1, 2005; 26(4): 779 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Edwards, I. M. Berquin, H. Sun, J. T. O'Flaherty, L. W. Daniel, M. J. Thomas, L. L. Rudel, R. L. Wykle, and Y. Q. Chen Differential Effects of Delivery of Omega-3 Fatty Acids to Human Cancer Cells by Low-Density Lipoproteins versus Albumin Clin. Cancer Res., December 15, 2004; 10(24): 8275 - 8283. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Wallace Nutritional and Botanical Modulation of the Inflammatory Cascade--Eicosanoids, Cyclooxygenases, and Lipoxygenases-- As an Adjunct in Cancer Therapy Integr Cancer Ther, March 1, 2002; 1(1): 7 - 37. [Abstract] [PDF] |
||||
![]() |
B. E. Cowing and K. E. Saker Polyunsaturated Fatty Acids and Epidermal Growth Factor Receptor/Mitogen-Activated Protein Kinase Signaling in Mammary Cancer J. Nutr., April 1, 2001; 131(4): 1125 - 1128. [Abstract] [Full Text] |
||||
![]() |
M. Wang, Y. E. Liu, J. Ni, B. Aygun, I. D. Goldberg, and Y. E. Shi Induction of Mammary Differentiation by Mammary-derived Growth Inhibitor-related Gene That Interacts with an {{omega}}-3 Fatty Acid on Growth Inhibition of Breast Cancer Cells Cancer Res., November 1, 2000; 60(22): 6482 - 6487. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |